Leukemia

Iclusig approved for rare leukemias

(HealthDay)—Iclusig (ponatinib) has been approved by the U.S. Food and Drug Administration to treat two rare forms of leukemia..

Dec 16, 2012
popularity not rated yet | comments 0

Clinical trial delivers good results in leukemia patients

Huntsman Cancer Institute (HCI) researchers Michael Deininger, M.D., Ph.D., and Thomas O'Hare, Ph.D., were part of a team that found a potent oral drug, ponatinib, effective in patients who have developed resistance to standard ...

Nov 30, 2012
popularity not rated yet | comments 0

Latest Spotlight News

People trust typical-looking faces most

Being "average" is often considered a bad thing, but new research suggests that averageness wins when people assess the trustworthiness of a face. The research indicates that, while typical-looking faces ...